Scienture Holdings Inc (SCNX)

Jan 02, 2026

Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 02, 2026

Jan 02, 2026

MSN Money - MSN

Jan 02, 2026

Dec 31, 2025

Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn

Dec 31, 2025

Dec 31, 2025

Scienture Holdings, Inc.Common Stock (Nasdaq:SCNX) Stock Quote - FinancialContent

Dec 31, 2025

Dec 28, 2025

Scienture Holdings, Inc. (SCNX) - Zacks Investment Research

Dec 28, 2025

Dec 23, 2025

Scienture Prepares Launch Of REZENOPY, Its Highest-Strength Naloxone Nasal Spray - Nasdaq

Dec 23, 2025

Dec 23, 2025

SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - The Globe and Mail

Dec 23, 2025

Dec 22, 2025

Scienture to launch high-strength naloxone nasal spray in Q2 2026 - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

Is Scienture Holdings Inc stock near bottom after declineJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - moha.gov.vn

Dec 22, 2025

Dec 22, 2025

Scienture (SCNX) Advances with REZENOPY Nasal Spray Launch - GuruFocus

Dec 22, 2025

Dec 22, 2025

Scienture to launch high-strength naloxone nasal spray in Q2 2026 By Investing.com - Investing.com South Africa

Dec 22, 2025

Dec 22, 2025

Scienture provides update on the commercial launch of Rezenopy - marketscreener.com

Dec 22, 2025

Dec 22, 2025

Scienture Provides Update On The Commercial Launch Of Rezenopy - TradingView — Track All Markets

Dec 22, 2025

Dec 22, 2025

New 10 mg overdose nasal spray set to reach U.S. market in 2026 - Stock Titan

Dec 22, 2025

Dec 22, 2025

Why Scienture Holdings Inc. stock is trending among retail tradersPrice Volatility Patterns & Master Technical Analysis With Free Tools - bollywoodhelpline.com

Dec 22, 2025

Dec 20, 2025

Is Scienture Holdings Inc. stock a top momentum playPortfolio Performance Summary & Low Drawdown Investment Strategies - Улправда

Dec 20, 2025

Dec 20, 2025

Will Scienture Holdings Inc. (4E4) stock announce a stock split2025 Retail Activity & Precise Swing Trade Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

How Scienture Holdings Inc. stock trades during market volatility2025 Technical Overview & Precise Swing Trade Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Is Scienture Holdings Inc. (4E4) stock included in top ETFs2025 Winners & Losers & Free High Return Stock Watch Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Scienture Holdings Inc. stock reacts to inflationary pressuresWeekly Trade Review & Risk Controlled Swing Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Scienture Holdings Inc. stock a good choice for value investorsWeekly Trade Report & Free Weekly Watchlist of Top Performers - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Scienture Holdings Inc. stock positioned for digital transformationTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber

Dec 19, 2025

Dec 19, 2025

What analyst consensus implies for Scienture Holdings Inc. (4E4) stockShort Setup & Reliable Breakout Stock Forecasts - DonanımHaber

Dec 19, 2025

Dec 14, 2025

Movement Recap: Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn

Dec 14, 2025

Dec 14, 2025

Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn

Dec 14, 2025

Dec 11, 2025

Scienture, BlinkRx announce strategic collaboration to expand access to Arbli - Yahoo Finance

Dec 11, 2025

Dec 10, 2025

Why Is Scienture Stock Gaining Today? - Benzinga

Dec 10, 2025

Dec 10, 2025

Scienture and BlinkRx partner to expand access to liquid losartan By Investing.com - Investing.com Australia

Dec 10, 2025

Dec 10, 2025

SCNX FinancialsIncome Statement - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times

Dec 10, 2025

Dec 10, 2025

Scienture and BlinkRx partner to expand access to liquid losartan - Investing.com India

Dec 10, 2025

Dec 10, 2025

Scienture (NASDAQ: SCNX) taps BlinkRx to launch Arbli, first ready-to-use losartan oral suspension in Q1 2026 - Stock Titan

Dec 10, 2025

Dec 08, 2025

A significant driver of top-line growth: Scienture Holdings Inc (SCNX) - Setenews

Dec 08, 2025

Dec 05, 2025

Scienture Holdings, Inc. Cash Flow – HAM:4E4 - TradingView

Dec 05, 2025

Dec 05, 2025

Can Scienture Holdings Inc. (4E4) stock beat analyst consensusTrade Signal Summary & Consistent Return Strategy Ideas - Newser

Dec 05, 2025

Dec 05, 2025

Head to Head Analysis: Summit Therapeutics (NASDAQ:SMMT) and Scienture (NASDAQ:SCNX) - Defense World

Dec 05, 2025